Phathom Pharmaceuticals, Inc. - COM (PHAT)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
56.6M
Holdings value Q2 2024
$583M
Value change Q2 2024
+$44.3M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
112
Number of buys Q2 2024
64
Number of sells Q2 2024
-35
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 50.1K $907K +$244K $18.10 3
2024 Q2 56.6M $583M +$44.3M $10.30 113
2024 Q1 52.2M $555M +$60.4M $10.62 111
2023 Q4 46.7M $426M +$11.4M $9.13 115
2023 Q3 43.8M $453M +$5.27M $10.37 110
2023 Q2 42.8M $613M +$176M $14.32 103
2023 Q1 30.8M $220M +$28.3M $7.14 83
2022 Q4 28.2M $317M -$21.7M $11.22 83
2022 Q3 30.2M $334M +$38M $11.08 88
2022 Q2 27.3M $230M +$9.33M $8.44 88
2022 Q1 25.7M $349M -$176M $13.61 76
2021 Q4 28.6M $562M +$49.9M $19.67 82
2021 Q3 25.5M $820M +$19.2M $32.10 81
2021 Q2 24.9M $844M +$13.2M $33.85 77
2021 Q1 24.5M $919M +$1.76M $37.56 82
2020 Q4 24.5M $815M +$96.7M $33.22 75
2020 Q3 21.6M $794M -$7.64M $36.67 57
2020 Q2 21.8M $719M -$3.03M $32.91 59
2020 Q1 21.9M $566M +$3.22M $25.82 47
2019 Q4 21.8M $677M +$593M $31.14 40